A detailed history of Tower Research Capital LLC (Trc) transactions in Cytosorbents Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,981 shares of CTSO stock, worth $2,653. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,981
Previous 21,699 86.26%
Holding current value
$2,653
Previous $15,000 73.33%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.55 $13,102 - $29,012
-18,718 Reduced 86.26%
2,981 $4,000
Q2 2024

Aug 13, 2024

BUY
$0.7 - $1.01 $9,572 - $13,811
13,675 Added 170.43%
21,699 $15,000
Q1 2024

May 15, 2024

BUY
$0.86 - $1.07 $1,607 - $1,999
1,869 Added 30.37%
8,024 $7,000
Q4 2023

Feb 13, 2024

BUY
$1.08 - $1.94 $5,780 - $10,382
5,352 Added 666.5%
6,155 $6,000
Q3 2023

Nov 14, 2023

BUY
$1.86 - $4.03 $1,222 - $2,647
657 Added 450.0%
803 $1,000
Q2 2023

Aug 14, 2023

BUY
$2.37 - $3.65 $346 - $532
146 New
146 $0
Q3 2022

Nov 10, 2022

BUY
$1.2 - $2.46 $1,149 - $2,356
958 New
958 $1,000
Q2 2022

Aug 15, 2022

SELL
$1.76 - $3.22 $12,019 - $21,989
-6,829 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$2.88 - $4.23 $81,144 - $119,180
-28,175 Reduced 80.49%
6,829 $22,000
Q4 2021

Feb 14, 2022

BUY
$4.05 - $8.11 $26,555 - $53,177
6,557 Added 23.05%
35,004 $146,000
Q3 2021

Nov 15, 2021

SELL
$7.0 - $9.71 $2,289 - $3,175
-327 Reduced 1.14%
28,447 $231,000
Q2 2021

Aug 16, 2021

BUY
$7.55 - $9.42 $183,434 - $228,868
24,296 Added 542.56%
28,774 $218,000
Q1 2021

May 17, 2021

SELL
$8.23 - $11.48 $897 - $1,251
-109 Reduced 2.38%
4,478 $39,000
Q4 2020

Feb 16, 2021

SELL
$7.65 - $8.98 $249,642 - $293,044
-32,633 Reduced 87.68%
4,587 $36,000
Q3 2020

Nov 16, 2020

BUY
$7.37 - $11.54 $225,330 - $352,823
30,574 Added 460.04%
37,220 $297,000
Q2 2020

Aug 13, 2020

BUY
$6.28 - $10.59 $41,736 - $70,381
6,646 New
6,646 $66,000
Q1 2020

May 15, 2020

SELL
$3.77 - $7.73 $14,974 - $30,703
-3,972 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$3.61 - $5.22 $6,158 - $8,905
1,706 Added 75.29%
3,972 $15,000
Q3 2019

Nov 05, 2019

SELL
$4.33 - $7.63 $2,875 - $5,066
-664 Reduced 22.66%
2,266 $11,000
Q2 2019

Aug 13, 2019

SELL
$5.92 - $7.78 $14,882 - $19,558
-2,514 Reduced 46.18%
2,930 $20,000
Q1 2019

May 14, 2019

BUY
$6.82 - $8.56 $33,083 - $41,524
4,851 Added 818.04%
5,444 $41,000
Q4 2018

Feb 14, 2019

BUY
$7.05 - $12.64 $4,180 - $7,495
593 New
593 $5,000
Q2 2018

Aug 15, 2018

SELL
$6.9 - $12.35 $7,396 - $13,239
-1,072 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$6.55 - $8.2 $1,925 - $2,410
294 Added 37.79%
1,072 $8,000
Q4 2017

Feb 09, 2018

BUY
$5.9 - $7.05 $4,590 - $5,484
778
778 $5,000

Others Institutions Holding CTSO

About Cytosorbents Corp


  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $38.8M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.